BRIXADI is a specialized medication designed to aid those struggling with opioid addiction, also known as opioid use disorder (OUD). This extended-release injection of buprenorphine targets the complex ways that opioid addiction affects brain chemistry and behavior. Opioid addiction can alter how the brain processes rewards, making it difficult for individuals to control their urges to seek out opioids, which can lead to physical dependence and withdrawal symptoms when attempting to quit.

BRIXADI is administered only by healthcare providers through a restricted program to ensure safety, considering the serious risks associated with opioid use. The brand emphasizes recovery as a journey that may include medication, counseling, and community support. Alongside its primary medication, BRIXADI offers resources for recovery, including support networks, counseling services, and important safety information to assist individuals in their path to reclaiming their lives. Understanding the need for professional help, BRIXADI provides comprehensive guidance for effective treatment.